Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Product Launch

23 Sep 2009 07:00

RNS Number : 4943Z
Imaginatik PLC
23 September 2009
 



23 September 2009

Imaginatik plc

("Imaginatik" or the "Company")

Launch of ChemBioConnect

CambridgeSoft and Imaginatik launch Visual Collaboration Tool for Scientists

Imaginatik plc (AIM: IMTK), a leading provider of enterprise collaboration software, announces the launch of ChemBioConnect, an online collaboration tool for use by researchers in the chemistry, biotechnology and pharmaceutical industries.

Developed in conjunction with CambridgeSoft, ChemBioConnect allows scientists to draw, view, edit, archive and search chemical structures and biological systems in a secure, robust collaboration and idea management environment. The resource effectively allows for collaborative problem-solving among scientists by combining CambridgeSoft's chemically intelligent visual toolsets with Imaginatik's research-based, enterprise-scale system, comprised of software, services and a deep understanding of how human networks operate. This offering is targeted to meet the needs of research and development professionals in the areas of pharmaceuticals, bioscience, biotechnology, chemistry and food science.

"Professional chemists think and communicate visually, whether doodling on paper, working in teams at a whiteboard, or keeping a notebook," said Dr. Robin Spencer, Senior Research Fellow at Pfizer, Inc. "At Pfizer we have seen that marrying the ability to work visually with a secure collaborative innovation environment like ChemBioConnect gives our scientists a scalable and secure new way to capture ideas and solve challenging problems."

"Collaboration is vital in all forms of business activity, and chemistry and biology are not exceptions to this rule," said Mark Turrell, CEO of Imaginatik. "ChemBioConnect is the first in a series of industry specific modules of our core collaboration software platform, Idea Central, which we intend to launch in the years ahead, supporting our growth and market leadership position." 

"We are pleased to be working together with Imaginatik," said Michael G. Tomasic, President and CEO of CambridgeSoft. "With this collaboration we are ensuring that our customers benefit from the integration of CambridgeSoft's leading chemical and biological drawing software, ChemBioDraw, with Imaginatik's innovation engine to drive collaborative problem solving for new research insights and higher efficiency."

ChemBioConnect is being sold by Imaginatik with support from CambridgeSoft.

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

ICIS

Tel: 020 7651 8688

Caroline Evans-Jones / Hilary Millar

About Imaginatik

Imaginatik is the leading provider of Collective Intelligence solutions, including Collaborative Innovation, Open Innovation and Idea Management technology and services. Some of the leading companies in the world use Imaginatik's Idea Central software platform to identify and develop the important ideas and strategies that will drive the future of their business. For more than 10 years, Imaginatik has helped customers including CSC, Pfizer, Boeing, Chubb and Cargill achieve outstanding results with its highly configurable web-based software and experienced consulting team.

A World Economic Forum Technology Pioneer with offices in Boston, MA, and London, UK, Imaginatik is committed to ongoing research into the nature of human networks, innovation and collective problem solving. The company collaborates with several academic institutions including the IXL Center at Hult International Business School. Imaginatik is publicly traded on the London Stock Exchange [AIM:IMTK.L].

For further information please visit http://www.imaginatik.com

About CambridgeSoft

CambridgeSoft develops and markets life science enterprise solutions for pharmaceutical, biotechnology, chemical companies and scientific research organizations. Software products include enterprise, workgroup and desktop versions of Chem & Bio Office, including Chem & Bio Draw and E-Notebook, with knowledge management, chemical and biological informatics, and scientific database solutions. Web sites include ChemBioFinder.Com and ChemBioNews.Com for indexed database content and news, and SciStore.Com for e-commerce. CambridgeSoft has offices in the United StatesEurope and Asia Pacific. For more information, please go to www.cambridgesoft.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPUUPPBUPBGQP
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSFinal Results
11th Jun 20128:00 amRNSProposed Placing
17th Apr 20127:00 amRNSContract Wins
17th Apr 20127:00 amRNSTrading Update
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.